90 related articles for article (PubMed ID: 9688907)
1. Three noncontiguous peptides comprise binding sites on high-molecular-weight kininogen to neutrophils.
Khan MM; Kunapuli SP; Lin Y; Majluf-Cruz A; Cadena RA; Cooper SL; Colman RW
Am J Physiol; 1998 Jul; 275(1):H145-50. PubMed ID: 9688907
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-induced platelet aggregation is inhibited by the heptapeptide Leu271-Ala277 of domain 3 in the heavy chain of high molecular weight kininogen.
Kunapuli SP; Bradford HN; Jameson BA; DeLa Cadena RA; Rick L; Wassell RP; Colman RW
J Biol Chem; 1996 May; 271(19):11228-35. PubMed ID: 8626672
[TBL] [Abstract][Full Text] [Related]
3. High-molecular-weight kininogen preadsorbed to glass surface markedly reduces neutrophil adhesion.
Yung LY; Lim F; Khan MM; Kunapuli SP; Rick L; Colman RW; Cooper SL
Biomaterials; 2000 Feb; 21(4):405-14. PubMed ID: 10656323
[TBL] [Abstract][Full Text] [Related]
4. High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5).
Wachtfogel YT; DeLa Cadena RA; Kunapuli SP; Rick L; Miller M; Schultze RL; Altieri DC; Edgington TS; Colman RW
J Biol Chem; 1994 Jul; 269(30):19307-12. PubMed ID: 8034694
[TBL] [Abstract][Full Text] [Related]
5. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis.
Colman RW; Jameson BA; Lin Y; Johnson D; Mousa SA
Blood; 2000 Jan; 95(2):543-50. PubMed ID: 10627460
[TBL] [Abstract][Full Text] [Related]
6. Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen.
Chavakis T; Kanse SM; Pixley RA; May AE; Isordia-Salas I; Colman RW; Preissner KT
FASEB J; 2001 Nov; 15(13):2365-76. PubMed ID: 11689462
[TBL] [Abstract][Full Text] [Related]
7. Interactions between the contact system, neutrophils and fibrinogen.
Colman RW
Adv Exp Med Biol; 1990; 281():105-20. PubMed ID: 1966352
[TBL] [Abstract][Full Text] [Related]
8. Zinc-dependent conformational changes in domain D5 of high molecular mass kininogen modulate contact activation.
Herwald H; Mörgelin M; Svensson HG; Sjöbring U
Eur J Biochem; 2001 Jan; 268(2):396-404. PubMed ID: 11168375
[TBL] [Abstract][Full Text] [Related]
9. Studies on porcine high molecular weight kininogen. An improved method for the purification of porcine high molecular weight kininogen and cleavage of the kininogen by the action of porcine plasma kallikrein.
Mashiko H; Miyamoto K; Takahashi H
Comp Biochem Physiol B Biochem Mol Biol; 1998 Aug; 120(4):647-56. PubMed ID: 9854812
[TBL] [Abstract][Full Text] [Related]
10. The hyaluronan-binding serine protease from human plasma cleaves HMW and LMW kininogen and releases bradykinin.
Etscheid M; Beer N; Fink E; Seitz R; Johannes D
Biol Chem; 2002 Oct; 383(10):1633-43. PubMed ID: 12452440
[TBL] [Abstract][Full Text] [Related]
11. Fine mapping of the sequences in domain 5 of high molecular weight kininogen (HK) interacting with heparin and zinc.
Pixley RA; Lin Y; Isordia-Salas I; Colman RW
J Thromb Haemost; 2003 Aug; 1(8):1791-8. PubMed ID: 12911595
[TBL] [Abstract][Full Text] [Related]
12. Deletion mutagenesis of high molecular weight kininogen light chain. Identification of two anionic surface binding subdomains.
Kunapuli SP; DeLa Cadena RA; Colman RW
J Biol Chem; 1993 Feb; 268(4):2486-92. PubMed ID: 8428925
[TBL] [Abstract][Full Text] [Related]
13. Fourier transform infrared (FT-IR) spectroscopic studies of peptide models for interaction of the binding regions of high molecular weight kininogen and prekallikrein.
Lin Y; Li W; Wu J; Zhang H; Colman RW
Thromb Res; 1998 Apr; 90(2):65-72. PubMed ID: 9684759
[TBL] [Abstract][Full Text] [Related]
14. Molecular determinants of the interaction between human high molecular weight kininogen and Candida albicans cell wall: Identification of kininogen-binding proteins on fungal cell wall and mapping the cell wall-binding regions on kininogen molecule.
Karkowska-Kuleta J; Kedracka-Krok S; Rapala-Kozik M; Kamysz W; Bielinska S; Karafova A; Kozik A
Peptides; 2011 Dec; 32(12):2488-96. PubMed ID: 22074954
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of angiogenesis by a monoclonal antibody to kininogen as well as by kininostatin which block proangiogenic high molecular weight kininogen.
Colman RW
Int Immunopharmacol; 2002 Dec; 2(13-14):1887-94. PubMed ID: 12489802
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiogenesis by cleaved high molecular weight kininogen (HKa) and HKa domain 5.
McCrae KR; Doñate F; Merkulov S; Sun D; Qi X; Shaw DE
Curr Cancer Drug Targets; 2005 Nov; 5(7):519-28. PubMed ID: 16305348
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic activity of kininogen is mediated by inhibitory effects of domain 3 during arterial injury in vivo.
Hassan S; Sainz IM; Khan MM; Bradford HN; Isordia-Salas I; Kashem SW; Sartor RB; Colman RW
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2959-65. PubMed ID: 17293494
[TBL] [Abstract][Full Text] [Related]
18. Kinetic analysis of the role of zinc in the interaction of domain 5 of high-molecular weight kininogen (HK) with heparin.
Lin Y; Pixley RA; Colman RW
Biochemistry; 2000 May; 39(17):5104-10. PubMed ID: 10819977
[TBL] [Abstract][Full Text] [Related]
19. The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface.
DeLa Cadena RA; Colman RW
Protein Sci; 1992 Jan; 1(1):151-60. PubMed ID: 1304876
[TBL] [Abstract][Full Text] [Related]
20. High molecular weight kininogen binds to laminin--characterization and kinetic analysis.
Schousboe I; Nystrøm B
FEBS J; 2009 Sep; 276(18):5228-38. PubMed ID: 19691495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
